IAVI | Finanzwire

BRIEF

published on 02/03/2025 at 17:05, 1 month 11 days ago

Ebola Sudan Vaccine Candidate Deployed Amid Uganda Outbreak

IAVI Ebola Sudan Vaccine Trial Uganda Outbreak Ring Vaccination
PRESS RELEASE

published on 02/03/2025 at 17:00, 1 month 11 days ago

First Participants Vaccinated with IAVI’s Ebola Sudan Vaccine Candidate in Uganda Amid Ebola Outbreak
IAVI's investigational Ebola Sudan vaccine candidate is being evaluated in a ring vaccination trial led by WHO at Makerere University Lung Institute in Uganda amidst the country's sixth outbreak of the deadly virus

IAVI Vaccine Candidate Ebola Sudan Uganda Outbreak Ring Vaccination Trial
BRIEF

published on 12/13/2024 at 15:50, 3 months 1 day ago

IAVI and IPD Join Forces to Boost Vaccine Development in Africa

Africa Vaccine Development IAVI IPD Health Collaboration
PRESS RELEASE

published on 12/13/2024 at 15:45, 3 months 1 day ago

IAVI and IPD Sign Agreement Formalizing Collaboration to Advance Vaccine Development, Manufacturing, and Access in Africa
IAVI and IPD sign agreement to collaborate on vaccine development and manufacturing in Africa to address priority pathogens. Partnership aligns with Africa's vaccine manufacturing agenda and global pandemic preparedness priorities

Manufacturing Africa Vaccine Development IAVI IPD
BRIEF

published on 09/25/2024 at 14:55, 5 months 19 days ago

Africa CDC and IAVI Sign MoU to Boost Vaccine and Antibody Research in Africa

Vaccine Development MoU Antibody Research Africa CDC IAVI Partnership
PRESS RELEASE

published on 09/25/2024 at 14:50, 5 months 19 days ago

Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa
Africa CDC and IAVI sign MoU to enhance disease-fighting capacity and pandemic readiness in Africa, focusing on vaccine and antibody development, supply resilience, and health security

Vaccine Development IAVI MoU Africa CDC Health Security
BRIEF

published on 04/04/2024 at 15:05, 11 months 10 days ago

First Phase 2 Clinical Trial of Lassa Fever Vaccine Begins in Nigeria

Phase 2 Clinical Trial Global Health Lassa Fever Vaccine IAVI CEPI
PRESS RELEASE

published on 04/04/2024 at 15:00, 11 months 10 days ago

Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI
CEPI-funded study in Nigeria evaluates safety, tolerability, and immunogenicity of IAVI's Lassa fever vaccine candidate. First Phase 2 trial for any Lassa vaccine

Phase 2 Trial IAVI CEPI Lassa Fever Vaccine Candidate
PRESS RELEASE

published on 12/18/2023 at 15:00, 1 year 2 months ago

IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa
PRESS RELEASE

published on 07/07/2023 at 15:00, 1 year 8 months ago

Germany Issues Award to IAVI to Support Development of the MTBVAC Tuberculosis Vaccine Candidate

Published on 03/15/2025 at 00:00, 23 minutes ago

BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement
Published on 03/14/2025 at 23:20, 1 hour 3 minutes ago

Organto Foods Provides Update on Strategic Plans
Published on 03/14/2025 at 22:55, 1 hour 28 minutes ago

Alset AI Announces Filing of Audited Financial Statements
Published on 03/14/2025 at 21:59, 2 hours 24 minutes ago

Apex Critical Metals Corp. Announces Grant of Stock Options
Published on 03/14/2025 at 21:58, 2 hours 25 minutes ago

Reyna Silver Announces Final Tranche Closing of Previously Announced Non-Brokered Private Placement

View all ACCESSWIRE

Published on 03/14/2025 at 20:20, 4 hours 2 minutes ago

EQS-Adhoc: Gläubigerversammlung zur Anleihenverlängerung
Published on 03/14/2025 at 18:44, 5 hours 38 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/14/2025 at 18:02, 6 hours 20 minutes ago

Form 8.1(c) - Dalata Hotel Group PLC:
Published on 03/14/2025 at 17:55, 6 hours 27 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 03/14/2025 at 16:12, 8 hours 10 minutes ago

Thalassa Holdings Ltd: Trading Update

View all EQS

Published on 03/14/2025 at 18:55, 5 hours 27 minutes ago

Availability of ENGIE's 2024 Universal Registration Document
Published on 03/14/2025 at 18:00, 6 hours 23 minutes ago

Availability of the 2024 Universal Registration Document of OPmobility SE
Published on 03/14/2025 at 16:55, 7 hours 27 minutes ago

Closing of the agreement between ENGIE and the Belgian government
Published on 03/14/2025 at 11:34, 12 hours 48 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as at February 28, 2025
Published on 03/14/2025 at 08:44, 15 hours 39 minutes ago

Aéroports de Paris SA - €1bn dual-tranche new bond issue

View all LES ECHOS COMFI WIRE

News